OverviewSuggest Edit

GCANRx (The Greater Cannabis Company) is a biopharmaceutical company that is focused on the development and commercialization of cannabinoid delivery systems. Its focus is on commercializing technology developed by Pharmedica for transmucosal delivery of legal medical or recreational cannabis and cannabinoids.
TypePrivate
Founded2018
HQPikesville, US
Websitegcanrx.com

Locations

GCANRx is headquartered in
Pikesville, United States

Location Map

Latest Updates

Employees (est.) (Jan 2020)2
Revenue (FY, 2019)$7.1 K(-92%)
Cybersecurity ratingBMore

Key People/Management at GCANRx

Aitan Zacharin

Aitan Zacharin

CEO, Director
Mark Radom

Mark Radom

VP, General Counsel
David Tavor

David Tavor

Director, Board of Directors
Hock S. Tan

Hock S. Tan

Chairman, Scientific Advisory Board
Show more

GCANRx Office Locations

GCANRx has an office in Pikesville
Pikesville, US (HQ)
15 Walker Ave #101
Show all (1)

GCANRx Financials and Metrics

Summary Metrics

Founding Date

2018
Show all financial metrics

GCANRx Revenue

GCANRx's revenue was reported to be $7.12 k in FY, 2019
USD

Revenue (Q2, 2020)

48.0k

Gross profit (Q2, 2020)

(46.0)

Gross profit margin (Q2, 2020), %

(0.1%)

Net income (Q2, 2020)

1.1m

EBIT (Q2, 2020)

(81.9k)

Cash (30-Jun-2020)

228.5k
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

209.095.4k7.1k

Cost of goods sold

109.03.1k

Gross profit

100.04.0k

Gross profit Margin, %

48%56%
Quarterly
USDQ3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

136.0136.02.3k48.0k

Cost of goods sold

66.072.048.1k

Gross profit

70.064.0(46.0)

Gross profit Margin, %

51%47%0%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

993.059.9k24.7k

Current Assets

993.059.9k52.7k

Goodwill

89.7k

Total Assets

993.0149.6k52.7k
Quarterly
USDQ3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

993.0993.087.7k164.9k81.0k45.8k295.3k228.5k

Accounts Receivable

23.6k

Prepaid Expenses

25.0k

Current Assets

993.0993.087.7k164.9k106.0k45.8k323.3k252.1k
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(807.2k)(839.1k)(1.6m)

Depreciation and Amortization

10.3k20.0k

Accounts Payable

53.7k74.7k(383.0)

Cash From Operating Activities

(36.3k)(100.1k)(285.2k)
Quarterly
USDQ3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(775.4k)(85.2k)(154.5k)(863.5k)(138.3k)(426.1k)(552.6k)(1.2m)(109.1k)

Depreciation and Amortization

5.3k5.0k10.0k15.0k

Accounts Payable

39.9k5.6k24.5k31.3k(5.9k)(8.2k)(8.2k)(12.7k)(9.3k)

Cash From Operating Activities

(30.8k)(34.5k)(28.0k)(72.3k)(145.0k)(228.9k)(264.0k)(131.0k)(210.8k)
USDQ3, 2017

Debt/Equity

-0.2 x

Debt/Assets

76 x
Show all financial metrics

GCANRx Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

GCANRx Online and Social Media Presence

Embed Graph

GCANRx Frequently Asked Questions

  • When was GCANRx founded?

    GCANRx was founded in 2018.

  • Who are GCANRx key executives?

    GCANRx's key executives are Aitan Zacharin, Mark Radom and David Tavor.

  • How many employees does GCANRx have?

    GCANRx has 2 employees.

  • What is GCANRx revenue?

    Latest GCANRx annual revenue is $7.1 k.

  • What is GCANRx revenue per employee?

    Latest GCANRx revenue per employee is $3.6 k.

  • Who are GCANRx competitors?

    Competitors of GCANRx include 22nd Century Group, Anandia Labs and CLS Holdings USA.

  • Where is GCANRx headquarters?

    GCANRx headquarters is located at 15 Walker Ave #101, Pikesville.

  • Where are GCANRx offices?

    GCANRx has an office in Pikesville.

  • How many offices does GCANRx have?

    GCANRx has 1 office.